Alpha Cognition (ACOG) Non-Current Assets (2023 - 2026)
Alpha Cognition (ACOG) posted quarterly Non-Current Assets of $719963.0 for Q4 2025, up 48.21% year-over-year from $485760.0 in Q4 2024, and up 20.08% quarter-over-quarter from $599563.0 in Q3 2025.
Alpha Cognition (ACOG) Non-Current Assets (2023 - 2026) Analysis & Trends
Alpha Cognition's Non-Current Assets history runs 3 years deep, the most recent figure standing at $719963.0 for Q4 2025.
- In Q4 2025, Non-Current Assets rose 48.21% year-over-year to $719963.0; the TTM figure through Dec 2025 stood at $2.3 million (up 8.68% YoY), while the FY2025 annual figure was $719963.0, up 48.21% from the prior year.
- Non-Current Assets for Q4 2025 stood at $719963.0, up from $599563.0 in the prior quarter.
- The five-year high for Non-Current Assets was $719963.0 in Q4 2025, with the low at $474735.0 in Q2 2025.
- The 3-year median for Non-Current Assets is $523735.5 (2023), against an average of $548122.2.
- Peak annual rise in Non-Current Assets reached 48.21% in 2025, while the deepest fall reached 16.42% in 2025.
- Alpha Cognition's Non-Current Assets stood at $533731.0 in 2023, then retreated by 8.99% to $485760.0 in 2024, then soared by 48.21% to $719963.0 in 2025.
- Business Quant data shows ACOG's Non-Current Assets at $719963.0 in Q4 2025, $599563.0 in Q3 2025, and $474735.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.59 Bn | 131.73 Bn | 2.84 Bn | 14.88 Bn |
| 2 | Regeneron Pharmaceuticals | 86.21 Bn | 78.22 Bn | 3.93 Bn | 23.28 Bn |
| 3 | Argenx Se | 65.65 Bn | 60.47 Bn | 1.37 Bn | 1.96 Bn |
| 4 | Moderna | 57.67 Bn | 52.53 Bn | 52.00 Mn | 5.15 Bn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | 1.96 Bn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn | 938.60 Mn |
| 7 | BioNTech SE | 27.90 Bn | 9.51 Bn | 668.28 Mn | 6.80 Bn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn | 468.65 Mn |
| 9 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - | 18.06 Bn |
| 10 | Alpha Cognition | 208.05 Mn | 166.61 Mn | 5.70 Mn | 6.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.59 Mn |
| Dec 31, 2025 | 719,963.00 |
| Sep 30, 2025 | 599,563.00 |
| Jun 30, 2025 | 474,735.00 |
| Mar 31, 2025 | 489,463.00 |
| Dec 31, 2024 | 485,760.00 |
| Sep 30, 2024 | 513,740.00 |
| Jun 30, 2024 | 568,023.00 |
| Dec 31, 2023 | 533,731.00 |